IPP Bureau
Lonza launches Singapore Media Development Lab to cut biomanufacturing risk
By IPP Bureau - March 27, 2026
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
MGM Healthcare builds world’s largest intestinal transplant program in 3 years
By IPP Bureau - March 27, 2026
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
HDFC Bank, Smile Foundation launch 8 mobile medical units to serve 4 lakh in remote north India
By IPP Bureau - March 27, 2026
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
India gets first real-time GLP-1 therapy monitoring platform
By IPP Bureau - March 27, 2026
As Tracky launches integrated health solution
CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG
By IPP Bureau - March 27, 2026
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
Cambrex advances $120M US API expansion with Charles City Engineering milestone
By IPP Bureau - March 27, 2026
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
Northamptonshire NHS Trust ditches disposable cups in bold sustainability move
By IPP Bureau - March 27, 2026
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
Ibex Medical Analytics joins forces with HNL Lab Medicine to supercharge AI diagnostics
By IPP Bureau - March 26, 2026
The collaboration will see HNL Lab Medicine deploy Ibex’s cutting-edge AI solution, Ibex Prostate, for biopsies and transurethral resection of the prostate (TURP), boosting both diagnostic accuracy and workflow efficiency
Semaglutide not a “Quick Fix”: Top docs urge holistic approach as drug goes off patent in India
By IPP Bureau - March 26, 2026
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Merck strikes $6.7 billion deal to acquire terns, bolstering cancer pipeline
By IPP Bureau - March 26, 2026
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
New diabetes drug UBT251 shows strong phase 2 results in China
By IPP Bureau - March 26, 2026
Apollo Hospitals Jubilee Hills breaks robotic surgery records in Telangana, Andhra
By IPP Bureau - March 26, 2026
Doctors at the hospital highlighted that robotic-assisted surgery enhances precision through superior 3D visualisation and improved instrument flexibility
Alkem Laboratories launches affordable semaglutide injection in India
By IPP Bureau - March 26, 2026
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
Zealand Pharma launches major US research hub in Cambridge, Massachusetts
By IPP Bureau - March 26, 2026
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
